86 related articles for article (PubMed ID: 20096576)
1. Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy.
Bouyssou T; Hoenke C; Rudolf K; Lustenberger P; Pestel S; Sieger P; Lotz R; Heine C; Büttner FH; Schnapp A; Konetzki I
Bioorg Med Chem Lett; 2010 Feb; 20(4):1410-4. PubMed ID: 20096576
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of olodaterol, a novel inhaled beta2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models.
Bouyssou T; Casarosa P; Naline E; Pestel S; Konetzki I; Devillier P; Schnapp A
J Pharmacol Exp Ther; 2010 Jul; 334(1):53-62. PubMed ID: 20371707
[TBL] [Abstract][Full Text] [Related]
3. Use of 5-hydroxy-4H-benzo[1,4]oxazin-3-ones as beta2-adrenoceptor agonists.
Hoenke C; Bouyssou T; Tautermann CS; Rudolf K; Schnapp A; Konetzki I
Bioorg Med Chem Lett; 2009 Dec; 19(23):6640-4. PubMed ID: 19875286
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
Battram C; Charlton SJ; Cuenoud B; Dowling MR; Fairhurst RA; Farr D; Fozard JR; Leighton-Davies JR; Lewis CA; McEvoy L; Turner RJ; Trifilieff A
J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol.
Aparici M; Gavaldà A; Ramos I; Carcasona C; Otal R; Fernández-Blanco JA; Montero JL; García VM; López R; De Alba J; Doe C; Puig C; Vilella D; Miralpeix M
Eur J Pharmacol; 2016 Jan; 770():61-9. PubMed ID: 26656755
[TBL] [Abstract][Full Text] [Related]
6. The long-acting β2 -adrenoceptor agonist olodaterol attenuates pulmonary inflammation.
Wex E; Kollak I; Duechs MJ; Naline E; Wollin L; Devillier P
Br J Pharmacol; 2015 Jul; 172(14):3537-47. PubMed ID: 25824824
[TBL] [Abstract][Full Text] [Related]
7. Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol.
Casarosa P; Kollak I; Kiechle T; Ostermann A; Schnapp A; Kiesling R; Pieper M; Sieger P; Gantner F
J Pharmacol Exp Ther; 2011 Jun; 337(3):600-9. PubMed ID: 21357659
[TBL] [Abstract][Full Text] [Related]
8. The identification of indacaterol as an ultralong-acting inhaled beta2-adrenoceptor agonist.
Baur F; Beattie D; Beer D; Bentley D; Bradley M; Bruce I; Charlton SJ; Cuenoud B; Ernst R; Fairhurst RA; Faller B; Farr D; Keller T; Fozard JR; Fullerton J; Garman S; Hatto J; Hayden C; He H; Howes C; Janus D; Jiang Z; Lewis C; Loeuillet-Ritzler F; Moser H; Reilly J; Steward A; Sykes D; Tedaldi L; Trifilieff A; Tweed M; Watson S; Wissler E; Wyss D
J Med Chem; 2010 May; 53(9):3675-84. PubMed ID: 20402514
[TBL] [Abstract][Full Text] [Related]
9. Studies towards topical selective beta2-adrenoceptor agonists with a long duration of action.
Bouyssou T; Rudolf K; Hoenke C; Lustenberger P; Schnapp A; Konetzki I
Bioorg Med Chem Lett; 2009 Sep; 19(17):5237-40. PubMed ID: 19643607
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties.
Hegde SS; Hughes AD; Chen Y; Steinfeld T; Jasper JR; Lee TW; McNamara A; Martin WJ; Pulido-Rios MT; Mammen M
J Pharmacol Exp Ther; 2014 Oct; 351(1):190-9. PubMed ID: 25100753
[TBL] [Abstract][Full Text] [Related]
11. Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.
Glossop PA; Watson CA; Price DA; Bunnage ME; Middleton DS; Wood A; James K; Roberts D; Strang RS; Yeadon M; Perros-Huguet C; Clarke NP; Trevethick MA; Machin I; Stuart EF; Evans SM; Harrison AC; Fairman DA; Agoram B; Burrows JL; Feeder N; Fulton CK; Dillon BR; Entwistle DA; Spence FJ
J Med Chem; 2011 Oct; 54(19):6888-904. PubMed ID: 21870878
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of 8-(2-amino-1-hydroxyethyl)-6-hydroxy-1,4-benzoxazine-3(4H)-one derivatives as potent β
Yi C; Xing G; Wang S; Li X; Liu Y; Li J; Lin B; Woo AY; Zhang Y; Pan L; Cheng M
Bioorg Med Chem; 2020 Jan; 28(1):115178. PubMed ID: 31753798
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating arylsulfonamide groups.
Procopiou PA; Barrett VJ; Bevan NJ; Biggadike K; Butchers PR; Coe DM; Conroy R; Edney DD; Field RN; Ford AJ; Guntrip SB; Looker BE; McLay IM; Monteith MJ; Morrison VS; Mutch PJ; Richards SA; Sasse R; Smith CE
J Med Chem; 2009 Apr; 52(8):2280-8. PubMed ID: 19317397
[TBL] [Abstract][Full Text] [Related]
14. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).
Peretto I; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Cerri A; Menegon S; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Bassani F; Delcanale M; Imbimbo BP
J Med Chem; 2007 Apr; 50(7):1693-7. PubMed ID: 17352463
[TBL] [Abstract][Full Text] [Related]
15. The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating a urea group.
Procopiou PA; Barrett VJ; Ford AJ; Looker BE; Lunniss GE; Needham D; Smith CE; Somers G
Bioorg Med Chem; 2011 Oct; 19(20):6026-32. PubMed ID: 21925889
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 2. Synthesis and structure-activity relationships of alpha,alpha-cycloalkylglycine sulfonamides.
Fattori D; Rossi C; Fincham CI; Caciagli V; Catrambone F; D'Andrea P; Felicetti P; Gensini M; Marastoni E; Nannicini R; Paris M; Terracciano R; Bressan A; Giuliani S; Maggi CA; Meini S; Valenti C; Quartara L
J Med Chem; 2007 Feb; 50(3):550-65. PubMed ID: 17266207
[TBL] [Abstract][Full Text] [Related]
18. Identification of higenamine in Radix Aconiti Lateralis Preparata as a beta2-adrenergic receptor agonist1.
Bai G; Yang Y; Shi Q; Liu Z; Zhang Q; Zhu YY
Acta Pharmacol Sin; 2008 Oct; 29(10):1187-94. PubMed ID: 18817623
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approach.
Procopiou PA; Barrett VJ; Bevan NJ; Biggadike K; Box PC; Butchers PR; Coe DM; Conroy R; Emmons A; Ford AJ; Holmes DS; Horsley H; Kerr F; Li-Kwai-Cheung AM; Looker BE; Mann IS; McLay IM; Morrison VS; Mutch PJ; Smith CE; Tomlin P
J Med Chem; 2010 Jun; 53(11):4522-30. PubMed ID: 20462258
[TBL] [Abstract][Full Text] [Related]
20. Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.
Jin J; Budzik B; Wang Y; Shi D; Wang F; Xie H; Wan Z; Zhu C; Foley JJ; Webb EF; Berlanga M; Burman M; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Lainé DI
J Med Chem; 2008 Oct; 51(19):5915-8. PubMed ID: 18798607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
